These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2895937)

  • 1. GABA agonists in cebus monkeys with neuroleptic-induced persistent dyskinesias.
    Andersson U; Häggström JE
    Psychopharmacology (Berl); 1988; 94(3):298-301. PubMed ID: 2895937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. gamma-Acetylenic GABA in tardive dyskinesia.
    Casey DE; Gerlach J; Magelund G; Christensen TR
    Arch Gen Psychiatry; 1980 Dec; 37(12):1376-9. PubMed ID: 6108751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapeutic trial of gamma-vinyl GABA, an inhibitor of GABA transaminase, in tardive dyskinesias induced by neuroleptics].
    Lambert PA; Cantiniaux P; Chabannes JP; Tell GP; Schechter PJ; Koch-Weser J
    Encephale; 1982; 8(3):371-6. PubMed ID: 6137357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of tetrahydroisoxazolopyridinol (THIP) in tardive dyskinesia: a new gamma-aminobutyric acid agonist.
    Korsgaard S; Casey DE; Gerlach J; Hetmar O; Kaldan B; Mikkelsen LB
    Arch Gen Psychiatry; 1982 Sep; 39(9):1017-21. PubMed ID: 6126170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GABA agonist treatment improves tardive dyskinesia.
    Tamminga CA; Thaker GK; Ferraro TN; Hare TA
    Lancet; 1983 Jul; 2(8341):97-8. PubMed ID: 6134975
    [No Abstract]   [Full Text] [Related]  

  • 6. Antidyskinetic action of 3-PPP, a selective dopaminergic autoreceptor agonist, in Cebus monkeys with persistent neuroleptic-induced dyskinesias.
    Häggström JE; Gunne LM; Carlsson A; Wikström H
    J Neural Transm; 1983; 58(3-4):135-42. PubMed ID: 6663299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain gamma-aminobutyric acid abnormality in tardive dyskinesia. Reduction in cerebrospinal fluid GABA levels and therapeutic response to GABA agonist treatment.
    Thaker GK; Tamminga CA; Alphs LD; Lafferman J; Ferraro TN; Hare TA
    Arch Gen Psychiatry; 1987 Jun; 44(6):522-9. PubMed ID: 3034188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gamma vinyl GABA in the treatment of levodopa-induced dyskinesias in Parkinson's disease.
    Turjanski N; Lees AJ
    J Neurol Neurosurg Psychiatry; 1992 May; 55(5):413. PubMed ID: 1602321
    [No Abstract]   [Full Text] [Related]  

  • 9. Stereoselective uptake of the GABA-transaminase inhibitors gamma-vinyl GABA and gamma-acetylenic GABA into neurons and astrocytes.
    Schousboe A; Larsson OM; Seiler N
    Neurochem Res; 1986 Nov; 11(11):1497-505. PubMed ID: 3683730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gamma-vinyl GABA.
    Hammond EJ; Wilder BJ
    Gen Pharmacol; 1985; 16(5):441-7. PubMed ID: 2932363
    [No Abstract]   [Full Text] [Related]  

  • 11. GABA system: clinical research and treatment of tardive dyskinesia.
    Thaker GK; Hare TA; Tamminga CA
    Mod Probl Pharmacopsychiatry; 1983; 21():155-67. PubMed ID: 6419061
    [No Abstract]   [Full Text] [Related]  

  • 12. Involvement of GABA in the antinociceptive effect of gamma-acetylenic GABA (GAG), an inhibitor of GABA-transaminase.
    Sawynok J; Dickson C
    Gen Pharmacol; 1983; 14(6):603-7. PubMed ID: 6662342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and biochemical effects of gamma-vinyl Gaba in tardive dyskinesia.
    Gaio JM; Pollak P; Hommel M; Perret J
    J Neurol Neurosurg Psychiatry; 1987 Dec; 50(12):1674-8. PubMed ID: 3437301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association with persistent neuroleptic-induced dyskinesia of regional changes in brain GABA synthesis.
    Gunne LM; Häggström JE; Sjöquist B
    Nature; 1984 May 24-30; 309(5966):347-9. PubMed ID: 6727989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of sulpiride on persistent neuroleptic-induced dyskinesia in monkeys.
    Häggström JE
    Acta Psychiatr Scand Suppl; 1984; 311():103-8. PubMed ID: 6142586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of gamma-vinyl GABA in tardive dyskinesia.
    Korsgaard S; Casey DE; Gerlach J
    Psychiatry Res; 1983 Apr; 8(4):261-9. PubMed ID: 6136054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo action of enzyme-activated irreversible inhibitors of glutamic acid decarboxylase and gamma-aminobutyric acid transaminase in retina vs. brain.
    Cubells JF; Blanchard JS; Smith DM; Makman MH
    J Pharmacol Exp Ther; 1986 Aug; 238(2):508-14. PubMed ID: 3735130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gamma-vinyl-GABA treatment of tardive dyskinesia and other movement disorders.
    Stahl SM; Thornton JE; Simpson ML; Berger PA; Napoliello MJ
    Biol Psychiatry; 1985 Aug; 20(8):888-93. PubMed ID: 3861199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of gabaergic drugs on reserpine-induced oral dyskinesia.
    Peixoto MF; Araujo NP; Silva RH; Castro JP; Fukushiro DF; Faria RR; Zanier-Gomes PH; Medrano WA; Frussa-Filho R; Abílio VC
    Behav Brain Res; 2005 May; 160(1):51-9. PubMed ID: 15836900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of gamma-acetylenic GABA and gamma-vinyl GABA on synaptosomal release and uptake of GABA.
    Abdul-Ghani AS; Norris PJ; Smith CC; Bradford HF
    Biochem Pharmacol; 1981 Jun; 30(11):1203-9. PubMed ID: 7271818
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.